HomeProductsBioactive CompoundsProtein Kinase TargetsBTKOrelabrutinib
Chemical structure of CAS 1655504-04-3

Orelabrutinib

CAS No.1655504-04-3
MDL No.MFCD32184857
MFC26H25N3O3
MW427.50
InChI KeyMZPVEMOYADUARK-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1655504-04-3
Product NameOrelabrutinib

Biological Targets

BTK

Associated Conditions

autoimmune thrombocytopenic purpura·systemic lupus erythematosus·lymphoma·Waldenstrom macroglobulinemia·Hodgkins lymphoma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Orelabrutinib: First Approval.

Drugs • Vol. 81, Issue 4 • 2021
PMID: 33704654DOI: 10.1007/s40265-021-01482-5

Current Role and Emerging Evidence for Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma.

Hematology/oncology clinics of North America • Vol. 34, Issue 5 • 2020
PMID: 32861286DOI: 10.1016/j.hoc.2020.06.007

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Partial purification and properties of Enterobacter cloacae heat-stable enterotoxin.

Infection and immunity • Vol. 13, Issue 5 • 1976
PMID: 5376PMC: PMC420757DOI: 10.1128/iai.13.5.1307-1314.1976

Documentation

Similar Products